期刊文献+

血液透析患者脂代谢紊乱的临床研究

Clinical study on dislipidemia in hemodialysis patients
下载PDF
导出
摘要 目的探讨血液透析患者脂代谢紊乱的临床特征及原因。方法检测106例维持性血液透析患者空腹血脂,并对影响血脂水平及有关因素进行分析。结果血液透析患者脂代谢紊乱主要表现为血清甘油三脂(TG)、载脂蛋白B(Apo-LB)水平显著增高,高密度脂蛋白胆固醇(HDLC)显著降低。TG与血清白蛋白(Alb)、透析时体外循环血流量显著负相关(r=-0.398,r=-0.219);HDLC水平与Kt/V显著相关(r=-0.305)。血液透析患者高血压的发生率为73.6%,心血管病变为25%。伴心血管疾病的血液透析患者TG水平显著高于无心血管疾病者。结论血液透析患者脂代谢紊乱主要表现为TG、Apo-LB水平增高,HDLC水平降低。透析充分及透析时体外循环血流量及血清白蛋白水平影响血脂水平。 Objective To investigate the clinical characteristics and the causes of dislipidemia in hemodialysis patients. Method Fast serum lipid was measured and the causes related to dislipidemia were analyzed in 106 hemodialysis patients. Results Serum triglyceride, apolipoprotein B increased and high density lipoprotein cholesterol(HDLC) deceased significantly. The level of serum triglyceride was relate to serum albumin (r= - 0. 398, P〈0.01) and blood flow rate (r : - t). 219, P〈0. 05), and the level of HDLC was related to Kt/V (r = - 0. 305, P〈0. 01 ) significantly. TG level in patients with cardiovascular disease was higher than that in patients without cardiovascular disease. Conclusions Serum triglyceride, apolipoprotein B increased and HDLC deceased significantly in hemodialysis patients. The level of serum lipid was related to serum albumin, blood flow rate , serum bile acid and adequency of hemodialysis. TG levels in hemodialysis patients with cardiovascular disease were higher than that in hemodialysis patients without cardiovascular disease.
出处 《临床肾脏病杂志》 2006年第2期65-67,共3页 Journal Of Clinical Nephrology
关键词 血液透析 脂类 Hemodialysis Dislipidemia
  • 相关文献

参考文献10

  • 1Senti M, Romero R, Petro-Botet J, et al. Lipoprotein abnormalities in hyperlipidemic and normalipidemic men on hemodialysis with chronic renal failure. Kidney Int, 1991, 41:1394-1399.
  • 2陈灏珠.冠状动脉粥样硬化性心脏病[A].陈灏珠等编.内科学:第四版[C].北京:人民卫生出版社,1996.246~274.
  • 3Stephen GR, Katherine AK, Edwin AR. Dialysis-associated ischemic heart disease: Insights from coronary angiography. Kidey Int, 1984,25:653-659.
  • 4赵水平,肾脏疾病与高脂血症.见:赵水平,主编.临床血脂学.湖南:湖南科学技术出版社,1999,132—134.
  • 5Olmer M, Renucci JE, Planells R, et al. Preliminary evidence for a role of apoliporotein E alleles in identifying haemodialysis patients at high vascular risk. Nephrol Dial Transplant, 1997,12:691-693.
  • 6Mariusz K, Miroslaw S, Zhenmin N, et al. Abnormalities in hepatic.lipase in chronic renal failure role of excess parathyroid hormone. J Clin Invest, 1996,97:2167-2173.
  • 7Stefoni F, Scolari MP, Cianciolo G, et al. Membranes, technologies and long-term results in chronic haemodialysis. Nephrol Dial Transplant, 2000, 15:12-15.
  • 8Michaela K, Thomas Q, Christoph C, et al. Abnormalities in lipoprotein metabolism in hemodialysis patients. Kidney Int,1999, 171:248-250.
  • 9armine Z. Cardiovascular risk in uraemic patients-is it fully explained by classical risk factors? Nephrol Dial Transplant, 2000,15 : 454-457.
  • 10陈灏珠..心力衰竭..陈灏珠,主编..内科学.第四版..北京:人民卫生出版社,,1996..133—148..

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部